about
Radotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute Myeloid Leukemia CellsLIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem CellsAngioimmunoblastic T-Cell Lymphoma in a Patient with Klinefelter Syndrome.Healthcare-Associated Pneumonia among Hospitalized Patients: Is It Different from Community Acquired Pneumonia?Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis.Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.Comparable Allogeneic Hematopoietic Cell Transplantation Outcome of a Haplo-Identical Family Donor with an Alternative Donor in Adult Aplastic Anemia.BK polyomavirus encephalitis in a patient with thrombotic microangiopathy after an allogeneic hematopoietic stem cell transplant.Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death.Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type.Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (Kmm150).Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia.Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial.Estimation of the effect-site equilibration rate constant using the time-to-peak effect of muscle relaxants measured by train-of-four stimulation during general anesthesia induction.Rhein augments ATRA-induced differentiation of acute promyelocytic leukemia cellsEfficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working PartyMyositis in bilateral calves mimicking lymphoma on interim PET/CT in a patient with T-lymphoblastic lymphomaResponse to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohortsClinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantationHigh-grade nodal marginal zone lymphoma with diffuse bone marrow involvement and IgM-type monoclonal paraproteinemia: a case report and review of the literatureBone marrow metastasis of small cell lung carcinoma with spontaneous tumor lysis syndrome without hepatic metastasis at diagnosis: first case report in Korea and review of literatureDistinct Clinical Features of Plasma Cell Myeloma Patients Exhibiting Dysmorphic Plasma Cells: Association with More Plasma Cells at DiagnosisClinical Utility of 18F-Florbetaben PET for Detecting Amyloidosis Associated With Multiple Myeloma: A Prospective Case-Control StudyFavorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic SyndromeRadotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expressionComparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria ClonesTitle: Monosomal karyotype affecting outcomes of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remissionReduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic LeukemiaLate complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation
P50
Q28548235-A7D4B693-C237-4D0D-915D-5439ECEA5EF2Q36189956-632E6498-BB08-486D-8E3B-8559D114212FQ37126466-6BFF7E79-8862-423A-B673-8E10AFA1858EQ37628866-DF2E9E21-5BE9-4E98-AF80-790B0A12AFB8Q38700958-88F43788-4FC8-4B16-91D3-C9B71AA22A33Q38754508-D08C709A-9198-4A9D-A366-86FEADDEF3C1Q39606996-04474B86-999E-4D11-8508-2C1CE5D7227AQ40518899-BE46D10A-1C56-4B3D-A9B9-909C5A728C2AQ46038713-B07FFC1C-3D22-41E0-AAD1-E34A4E7B5D1AQ48785791-D4087477-6DDD-45ED-BB10-257D7359BC5FQ50021094-CA25C541-38E4-4EAA-82F4-E115E82A04B5Q50575980-E9A23B7C-05BE-4A46-89A2-BC8604B11844Q53153689-794DF130-623A-4A78-878C-B414751A290CQ55016936-74F683EC-8A9C-476F-89C9-C78E0A4E2FF5Q57212662-E13BA2EF-4480-4B86-9D2D-37B478DC9FB3Q57212738-70A4340F-5109-452A-906A-D06E9AC7D05AQ88201857-654989B2-E194-40BA-9827-3E8F39FB2AA0Q90728809-5263B15A-C71E-412D-8002-AE53618C1F87Q90924993-E2882D96-9EC7-4074-892F-AD594C4273D5Q91296344-3384B322-7C0A-4DC9-82E6-A082D5388290Q91296367-ACB2115E-3058-45C1-96FC-7740CC614DE4Q91333001-49F3FF0E-1B32-4E66-8977-1AB7AAB4F018Q91708267-7A5B3FFE-C379-4A6B-B3B7-2F9979216D80Q91802262-F33C4F06-A0F8-404B-A3FD-CBB2916D3CA5Q91910455-54B9F199-FA9D-4F6D-9668-1D68FC7C7868Q93088221-CD7D2296-8CA9-4F4E-BD65-21FE4A870EB4Q94470702-3D41F551-AD6B-4547-B636-80F10570A320Q95941006-27D8735D-7EB8-4D16-80CA-AF1C54BF33D3Q96581418-CE4AF9ED-B50B-4A1B-B444-692987339165
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Yunsuk Choi
@en
Yunsuk Choi
@nl
type
label
Yunsuk Choi
@en
Yunsuk Choi
@nl
prefLabel
Yunsuk Choi
@en
Yunsuk Choi
@nl
P31
P496
0000-0002-7983-8089